CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on the safety and efficacy of the MVA-BN vaccine for pregnant women and children in the context of the Mpox outbreak. It aims to address vaccine hesitancy through community engagement and a clinical trial assessing the vaccine's immunogenicity.
Mpox can cause severe complications in vulnerable groups such as pregnant women and children, necessitating targeted public health interventions and vaccine trials in these populations.
Limited data suggest the MVA-BN vaccine is safe for pregnant women and likely poses no risk to breastfed infants, but comprehensive human data are lacking.
Trials in endemic areas are crucial for evaluating the vaccine's safety and efficacy in real-world settings.Vaccine hesitancy, exacerbated by misinformation a…
UNIVERSITEIT ANTWERPEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Congo - Kinshasa, KINSHASA
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Padova
Type: Research institute
Activity type: Research Organisations
SME: No
Kenya, KISUMU
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
